In Translation

Teaming up to fight cancer
(continued)

Together, more than 200 physicians, molecular biologists, pharmacologists, physicists and genetic scientists are engaged in collaborative projects.

The biomedical technology program has 30 researchers by itself, according to Matthews.

"No other cancer center in the United States has a dedicated biomedical technologies program," said Matthews. "We believe this is the model for cancer programs of the future."

The partnership is integral to the UC Davis Cancer Center's efforts to become a National Cancer Institute-designated cancer center. With Lawrence Livermore researchers on board, the cancer center recently organized clinical research into six programs: molecular oncology; cancer biology in animals; developmental therapeutics (drug development); cancer etiology, prevention and control; prostate cancer and biomedical technology.

The union is still a work in progress. Some Lawrence Livermore scientists have established labs in remodeled space at the UC Davis Medical Center. Others are discussing how to mix and match interests.